Skip to main content

Closed

FENC: Fennec Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-11.0%

ROIC-9.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-3.7×

Current ratio6.98×

Fennec Pharmaceuticals Inc.

FENCNASDAQ Capital Market·USD·Closed

Fennec Pharmaceuticals Inc.

FENCNASDAQ·USD·Closed

$9.57

−3.43%

$9.57

−$0.34 (3.43%)

52W Range

69thpctl

Volume

0.32×avg

Mkt Cap

332.43MUSD

P/E

-31.2TTM

Div Yield

–ann

52W Range

69thpctl

Volume

0.32×avg

Market Cap

332.43MUSD

P/E Ratio

-31.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings